Literature DB >> 8478035

Alterations in calcium metabolism in young people at risk for primary hypertension. The Dutch Hypertension and Offspring Study.

I M van Hooft1, D E Grobbee, M Frölich, H A Pols, A Hofman.   

Abstract

Several disturbances in calcium metabolism have been reported in primary hypertensive subjects. It is, however, not clear whether these alterations predate the development of hypertension or occur as a consequence of high blood pressure. We studied indexes of calcium metabolism in three groups of normotensive children with different familial predispositions for hypertension, based on parental blood pressure levels, with two, one, or no hypertensive parents. Plasma intact parathyroid hormone [1-84] was higher in the offspring of hypertensive parents compared with offspring of normotensive parents (difference, 0.58 pmol/L; standard error of the difference [SED], 0.24; p = 0.02). Mean serum calcium levels were slightly reduced in the offspring of two hypertensive parents (-0.019 mmol/L, SED = 0.013, p = 0.17). Plasma magnesium and phosphate levels were lower in the offspring of hypertensive parents (-0.032 mmol/L [SED = 0.016, p = 0.05] and -0.045 mmol/L [SED = 0.024, p = 0.05], respectively). Mean 1.25-dihydroxyvitamin D3 levels were similar among the groups. No differences in dietary intake of calcium, phosphate, or fiber were found. Urinary calcium excretion per 24 hours and the ratio of 24-hour urinary calcium excretion to daily calcium intake were somewhat higher in the offspring of hypertensive parents. Renal fractional excretion of calcium was similar in the offspring of two hypertensive parents, and renal fractional excretion of phosphate was lower in the offspring of two hypertensive parents compared with offspring of two normotensive parents (-1.50%, SED = 0.74, p = 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478035     DOI: 10.1161/01.hyp.21.3.267

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  A pharmacogenetic approach to blood pressure in Lyon hypertensive rats. A chromosome 2 locus influences the response to a calcium antagonist.

Authors:  M Vincent; N J Samani; D Gauguier; J R Thompson; G M Lathrop; J Sassard
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

Authors:  Wonngarm Kittanamongkolchai; Kristin C Mara; Ramila A Mehta; Lisa E Vaughan; Aleksandar Denic; John J Knoedler; Felicity T Enders; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

3.  Lower bone mineral content in hypertensive compared with normotensive overweight Latino children and adolescents.

Authors:  Afrooz Afghani; Michael I Goran
Journal:  Am J Hypertens       Date:  2007-02       Impact factor: 2.689

4.  Computational analysis of candidate disease genes and variants for salt-sensitive hypertension in indigenous Southern Africans.

Authors:  Nicki Tiffin; Ayton Meintjes; Rajkumar Ramesar; Vladimir B Bajic; Brian Rayner
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

Review 5.  Nephrolithiasis: A Red Flag for Cardiovascular Risk.

Authors:  Alessia Gambaro; Gianmarco Lombardi; Chiara Caletti; Flavio Luciano Ribichini; Pietro Manuel Ferraro; Giovanni Gambaro
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.